Literature DB >> 33169027

What Pfizer's landmark COVID vaccine results mean for the pandemic.

Ewen Callaway.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; Vaccines

Year:  2020        PMID： 33169027     DOI： 10.1038/d41586-020-03166-8

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  17 in total

Review 1.  Current State of the First COVID-19 Vaccines.

Authors:  Birgit M Prüβ
Journal:  Vaccines (Basel)       Date:  2021-01-08

Review 2.  Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.

Authors:  Ioannis P Trougakos; Kimon Stamatelopoulos; Evangelos Terpos; Ourania E Tsitsilonis; Evmorfia Aivalioti; Dimitrios Paraskevis; Efstathios Kastritis; George N Pavlakis; Meletios A Dimopoulos
Journal:  J Biomed Sci       Date:  2021-01-12       Impact factor: 8.410

3.  Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.

Authors:  Hu Zhu; Catherine Z Chen; Srilatha Sakamuru; Jinghua Zhao; Deborah K Ngan; Anton Simeonov; Mathew D Hall; Menghang Xia; Wei Zheng; Ruili Huang
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.996

Review 4.  A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic.

Authors:  Chris R Triggle; Devendra Bansal; Hong Ding; Md Mazharul Islam; Elmoubashar Abu Baker Abd Farag; Hamad Abdel Hadi; Ali A Sultan
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

5.  Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.

Authors:  Michael S Piepenbrink; Jun-Gyu Park; Fatai S Oladunni; Ashlesha Deshpande; Madhubanti Basu; Sanghita Sarkar; Andreas Loos; Jennifer Woo; Phillip Lovalenti; Derek Sloan; Chengjin Ye; Kevin Chiem; Christopher W Bates; Reuben E Burch; Nathaniel B Erdmann; Paul A Goepfert; Vu L Truong; Mark R Walter; Luis Martinez-Sobrido; James J Kobie
Journal:  Cell Rep Med       Date:  2021-02-25

Review 6.  Harnessing Cellular Immunity for Vaccination against Respiratory Viruses.

Authors:  Nicholas W Lukacs; Carrie-Anne Malinczak
Journal:  Vaccines (Basel)       Date:  2020-12-21

7.  Filling the Gap Until Full Vaccine Deployment in the War on Coronavirus Disease-19.

Authors:  Sabrina Mattoli
Journal:  Infect Dis Ther       Date:  2021-01-09

Review 8.  Alternative strategies in cardiac preclinical research and new clinical trial formats.

Authors:  Fabian Philipp Kreutzer; Anna Meinecke; Kevin Schmidt; Jan Fiedler; Thomas Thum
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

Review 9.  SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.

Authors:  Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Ioana Roxana Bordea; Giuseppina Malcangi; Edit Xhajanka; Antonio Scarano; Felice Lorusso; Marco Farronato; Gianluca Martino Tartaglia; Ciro Gargiulo Isacco; Grazia Marinelli; Maria Teresa D'Oria; Denisa Hazballa; Luigi Santacroce; Andrea Ballini; Maria Contaldo; Francesco Inchingolo; Gianna Dipalma
Journal:  Microorganisms       Date:  2021-03-04

Review 10.  One year update on the COVID-19 pandemic: Where are we now?

Authors:  Sanjay Kumar Mishra; Timir Tripathi
Journal:  Acta Trop       Date:  2020-11-28       Impact factor: 3.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.